These experienced investors want to prove that funding advances in women’s health is ‘worth it’

Tracy Warren and Tammi Jantzen are working on growing their first company together, but the pair are far from new to the medtech game.

Both women have pivoted to running a company after years of working in investing in other early-stage technology companies — Warren has been a banker, venture capitalist and entrepreneur, while Jantzen was CFO of three early-stage venture capital funds. Their niche was “how to build a company around a technology,” Warren said.

Between them, the pair had raised funds for about 75 ventures, but when they stepped back and looked at that mass of businesses, they realized there were few truly dedicated to women-beneficial technology, she said.

“We kind of wanted to do something that meant more to us personally,” said Warren, the company’s CEO. “We’re both mothers, Tammy is actually a grandmother, and we wanted to bring more capital to women’s health.”

Warren and Jantzen launched Bucks County-based Astarte Medical in 2016. The company raised $5 million in a Series A round this spring and is using the funding to complete the development of its flagship product: NICUtrition, a suite of digital tools and diagnostics that supports feeding protocols, practice and decision-making in neonatal intensive care units (NICUs). (Astarte is an ancient Middle Eastern goddess associated with fertility.)

To read the full Technical.ly Philly article, click here.